Cargando…

Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence

BACKGROUND: Cervical cancer is a predominantly human papillomavirus (HPV)‐driven disease worldwide. However, its incidence is unexplainably low in western Asia, including Saudi Arabia. Using this paradigm, we investigated the role of HPV infection rate and host genetic predisposition in TP53 G72C si...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsbeih, Ghazi A., Al‐Harbi, Najla M., Bin Judia, Sara S., Khoja, Hatim A., Shoukri, Mohamed M., Tulbah, Asma M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485004/
https://www.ncbi.nlm.nih.gov/pubmed/28393355
http://dx.doi.org/10.1002/cncr.30635
_version_ 1783245984413777920
author Alsbeih, Ghazi A.
Al‐Harbi, Najla M.
Bin Judia, Sara S.
Khoja, Hatim A.
Shoukri, Mohamed M.
Tulbah, Asma M.
author_facet Alsbeih, Ghazi A.
Al‐Harbi, Najla M.
Bin Judia, Sara S.
Khoja, Hatim A.
Shoukri, Mohamed M.
Tulbah, Asma M.
author_sort Alsbeih, Ghazi A.
collection PubMed
description BACKGROUND: Cervical cancer is a predominantly human papillomavirus (HPV)‐driven disease worldwide. However, its incidence is unexplainably low in western Asia, including Saudi Arabia. Using this paradigm, we investigated the role of HPV infection rate and host genetic predisposition in TP53 G72C single nucleotide polymorphism (SNP) presumed to affect cancer incidence. METHODS: Patients treated between 1990 and 2012 were reviewed, and a series of 232 invasive cervical cancer cases were studied and compared with 313 matched controls without cancer. SNP was genotyped by way of direct sequencing. HPV linear array analysis was used to detect and genotype HPV in tumor samples. RESULTS: The incidence of cervical cancer revealed bimodal peaks at 42.5 years, with a slighter rebound at 60.8 years. Among all cases, 77% were HPV‐positive and 16 HPV genotypes were detected—mostly genotypes 16 (75%) and 18 (9%)—with no difference by age, histology, or geographical region. Although the TP53 G72C genotype was not associated with overall cervical cancer risk, it was significantly associated with HPV positivity (odds ratio, 0.57; 95% confidence interval, 0.36‐0.90; P = .016). Furthermore, the variant C allele was significantly overtransmitted in the population (P < .0003). CONCLUSION: Cervical cancer incidence displays bimodal curve peaking at a young age with secondary rebound at older age. The combination of relative low HPV infection and variant TP53 72C allele overtransmission provide a plausible explanation for the low incidence of cervical cancer in our population. Therefore, HPV screening and host SNP genotyping may provide more relevant biomarkers to gauge the risk of developing cervical cancer. Cancer 2017;123:2459–66. © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
format Online
Article
Text
id pubmed-5485004
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54850042017-07-11 Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence Alsbeih, Ghazi A. Al‐Harbi, Najla M. Bin Judia, Sara S. Khoja, Hatim A. Shoukri, Mohamed M. Tulbah, Asma M. Cancer Original Articles BACKGROUND: Cervical cancer is a predominantly human papillomavirus (HPV)‐driven disease worldwide. However, its incidence is unexplainably low in western Asia, including Saudi Arabia. Using this paradigm, we investigated the role of HPV infection rate and host genetic predisposition in TP53 G72C single nucleotide polymorphism (SNP) presumed to affect cancer incidence. METHODS: Patients treated between 1990 and 2012 were reviewed, and a series of 232 invasive cervical cancer cases were studied and compared with 313 matched controls without cancer. SNP was genotyped by way of direct sequencing. HPV linear array analysis was used to detect and genotype HPV in tumor samples. RESULTS: The incidence of cervical cancer revealed bimodal peaks at 42.5 years, with a slighter rebound at 60.8 years. Among all cases, 77% were HPV‐positive and 16 HPV genotypes were detected—mostly genotypes 16 (75%) and 18 (9%)—with no difference by age, histology, or geographical region. Although the TP53 G72C genotype was not associated with overall cervical cancer risk, it was significantly associated with HPV positivity (odds ratio, 0.57; 95% confidence interval, 0.36‐0.90; P = .016). Furthermore, the variant C allele was significantly overtransmitted in the population (P < .0003). CONCLUSION: Cervical cancer incidence displays bimodal curve peaking at a young age with secondary rebound at older age. The combination of relative low HPV infection and variant TP53 72C allele overtransmission provide a plausible explanation for the low incidence of cervical cancer in our population. Therefore, HPV screening and host SNP genotyping may provide more relevant biomarkers to gauge the risk of developing cervical cancer. Cancer 2017;123:2459–66. © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. John Wiley and Sons Inc. 2017-04-10 2017-07-01 /pmc/articles/PMC5485004/ /pubmed/28393355 http://dx.doi.org/10.1002/cncr.30635 Text en © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Alsbeih, Ghazi A.
Al‐Harbi, Najla M.
Bin Judia, Sara S.
Khoja, Hatim A.
Shoukri, Mohamed M.
Tulbah, Asma M.
Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence
title Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence
title_full Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence
title_fullStr Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence
title_full_unstemmed Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence
title_short Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence
title_sort reduced rate of human papillomavirus infection and genetic overtransmission of tp53 72c polymorphic variant lower cervical cancer incidence
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485004/
https://www.ncbi.nlm.nih.gov/pubmed/28393355
http://dx.doi.org/10.1002/cncr.30635
work_keys_str_mv AT alsbeihghazia reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence
AT alharbinajlam reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence
AT binjudiasaras reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence
AT khojahatima reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence
AT shoukrimohamedm reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence
AT tulbahasmam reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence